These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10987178

  • 1. Immunohistochemically visualized localisation of gangliosides Glac2 (GD3) and Gtri2 (GD2) in cells of human intracranial tumors.
    Mennel HD, Bosslet K, Geissel H, Bauer BL.
    Exp Toxicol Pathol; 2000 Aug; 52(4):277-85. PubMed ID: 10987178
    [Abstract] [Full Text] [Related]

  • 2. Expression of GD2-epitopes in human intracranial tumors and normal brain.
    Mennel HD, Bosslet K, Wiegandt H, Sedlacek HH, Bauer BL, Rodden AF.
    Exp Toxicol Pathol; 1992 Oct; 44(6):317-24. PubMed ID: 1280497
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
    Mennel HD, Lell B.
    Clin Neuropathol; 2005 Oct; 24(1):13-8. PubMed ID: 15696779
    [Abstract] [Full Text] [Related]

  • 4. Gangliosides in meningiomas: correlation of Glac2 to intermediary filament.
    Pausch G, Jennemann R, Mennel HD, Bauer BL, Rodden AF, Wiegandt H.
    Acta Neurochir (Wien); 1992 Oct; 117(3-4):166-71. PubMed ID: 1414518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
    Wikstrand CJ, Fredman P, Svennerholm L, Bigner DD.
    Prog Brain Res; 1994 Oct; 101():213-23. PubMed ID: 7518092
    [Abstract] [Full Text] [Related]

  • 10. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
    Nishio M, Furukawa K.
    Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
    Söling A, Plugge EM, Schmitz M, Weigle B, Jacob R, Illert J, Holzhausen HJ, Rainov NG.
    Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.
    Dobrenkov K, Ostrovnaya I, Gu J, Cheung IY, Cheung NK.
    Pediatr Blood Cancer; 2016 Oct; 63(10):1780-5. PubMed ID: 27304202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
    Iwasawa T, Zhang P, Ohkawa Y, Momota H, Wakabayashi T, Ohmi Y, Bhuiyan RH, Furukawa K, Furukawa K.
    Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.